STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 22,821	$ 16,470
General and administrative	7,467	5,497
Total operating expenses	30,288	21,967
Loss from operations	(30,288)	(21,967)
Other income, net	823	667
Net loss	$ (29,465)	$ (21,300)
Per share information:
Net loss per share of common stock, basic and diluted	$ (0.63)	$ (0.47)
Weighted average common shares outstanding, basic and diluted	47,066,427	45,121,955
Comprehensive loss
Net loss	$ (29,465)	$ (21,300)
Unrealized loss on marketable securities, net of tax	(1,602)
Comprehensive loss	$ (31,067)	$ (21,300)